Results 21 to 30 of about 30,205 (229)

Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2022
Background Limited data exist about effective regimens for pharmacological thromboprophylaxis in children with acute coronavirus disease 2019 (COVID‐19) and multisystem inflammatory syndrome in children (MIS‐C).
Anna H. Schmitz   +6 more
doaj   +1 more source

Cancer and thrombosis: Managing the risks and approaches to thromboprophylaxis [PDF]

open access: yes, 2006
Patients with cancer are at increased risk of venous thromboembolism (VTE) compared with patients without cancer. This results from both the prothrombotic effects of the cancer itself and iatrogenic factors, such as chemotherapy, radiotherapy, indwelling
Altinbas M   +36 more
core   +1 more source

THROMBOPROPHYLAXIS;

open access: yesThe Professional Medical Journal, 2012
Maternal obesity (body mass index, BMI≥30kg/m²) is a global health problem. Significant evidence is available that it is directlyassociated with an increased risk of venous thromboembolic events in pregnancy and puerperium. Objective: This study aims to assess ourcurrent management protocols for thromboprophylaxis and to improve them according to ...
NAUSHEEN NABEEL   +2 more
openaire   +2 more sources

Enhanced thromboprophylaxis in critically ill patients with COVID-19 infection

open access: yesThrombosis Update, 2021
Background: Patients with severe SARS-CoV-2 infection have been shown to have abnormal coagulation parameters and are at increased risk of thromboembolism. The optimal thromboprophylaxis regimen that minimizes thrombosis without increased risk of serious
R.L. Kummer   +8 more
doaj   +1 more source

Extended thromboprophylaxis with betrixaban in acutely ill medical patients [PDF]

open access: yes, 2016
BACKGROUND: Patients with acute medical illnesses are at prolonged risk for venous thrombosis. However, the appropriate duration of thromboprophylaxis remains unknown.
. Lodigiani, M   +18 more
core   +1 more source

Hematologists’ awareness of venous thromboembolism in multiple myeloma: a national survey in China

open access: yesAnnals of Medicine, 2023
Background Venous thromboembolism (VTE) is one of the most common and severe complications of multiple myeloma (MM). The aim of this study was to learn about the current awareness regarding MM-associated VTE among Chinese hematologists.Methods A ...
Qun Li   +8 more
doaj   +1 more source

Pulmonary embolism and mortality following total ankle replacement: a data linkage study using the NJR data set [PDF]

open access: yes, 2016
OBJECTIVE: To determine the mortality rate following total ankle replacement (TAR) and incidence of 90 day pulmonary embolism (PE) along with the associated risk factors.
Cro, Suzie   +3 more
core   +1 more source

Thromboprophylaxis in critical care

open access: yesIntensive Care Medicine, 2022
Contains fulltext : 290892.pdf (Publisher’s version ) (Open Access)
Julie Helms   +2 more
openaire   +5 more sources

Characterization of the complications associated with plasma exchange for thrombotic thrombocytopaenic purpura and related thrombotic microangiopathic anaemias: a single institution experience. [PDF]

open access: yes, 2014
Plasma exchange (PEX) is a life-saving therapeutic procedure in patients with thrombotic thrombocytopaenic purpura (TTP) and other thrombotic microangiopathic anaemias (TMAs). However, it may be associated with significant complications, exacerbating the
Collier, D   +5 more
core   +2 more sources

VTE prevention in medical inpatients - Current approach and controversies

open access: yesThrombosis Update, 2023
Hospitalisation with an acute medical illness represents a significant risk factor for venous thromboembolism. Identification of patients at high risk of VTE at hospital admission and provision of appropriate thromboprophylaxis is a key intervention to ...
Rachel E. Clapham   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy